SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BOVOLENTA, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.543
EU - Europa 1.805
AS - Asia 1.207
SA - Sud America 216
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
Totale 7.797
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.515
PL - Polonia 564
SG - Singapore 545
CN - Cina 397
IT - Italia 346
DE - Germania 256
BR - Brasile 198
UA - Ucraina 182
TR - Turchia 142
GB - Regno Unito 126
SE - Svezia 104
FI - Finlandia 66
ID - Indonesia 43
BE - Belgio 42
FR - Francia 26
CA - Canada 24
HK - Hong Kong 23
NL - Olanda 22
RU - Federazione Russa 18
VN - Vietnam 14
IE - Irlanda 10
CZ - Repubblica Ceca 9
AR - Argentina 8
IN - India 8
ZA - Sudafrica 8
AT - Austria 6
BD - Bangladesh 6
IQ - Iraq 6
EU - Europa 5
HR - Croazia 5
CH - Svizzera 4
ES - Italia 4
BY - Bielorussia 3
CL - Cile 3
CO - Colombia 3
KG - Kirghizistan 3
LB - Libano 3
LT - Lituania 3
AU - Australia 2
BG - Bulgaria 2
DZ - Algeria 2
IR - Iran 2
KE - Kenya 2
MA - Marocco 2
PA - Panama 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
CR - Costa Rica 1
DK - Danimarca 1
EG - Egitto 1
GL - Groenlandia 1
JP - Giappone 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
QA - Qatar 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 7.797
Salva come PNG Salva come JPEG
Città #
Warsaw 564
Woodbridge 554
Fairfield 515
Ann Arbor 386
Houston 327
Chandler 322
Ashburn 253
Singapore 226
Jacksonville 218
Santa Clara 217
Seattle 211
Wilmington 200
Cambridge 174
Ferrara 126
Izmir 96
Nanjing 83
New York 61
Princeton 60
Milan 55
Beijing 53
Shanghai 49
San Diego 48
Boardman 45
Jakarta 41
Munich 38
Bremen 37
Brussels 37
Dearborn 30
Nanchang 23
Falls Church 22
Los Angeles 22
Helsinki 21
Hong Kong 21
Tianjin 20
Shenyang 19
Kunming 16
London 16
Bologna 15
Des Moines 13
Hebei 13
Dong Ket 12
Redwood City 12
Changsha 11
Auburn Hills 10
Council Bluffs 10
Jinan 10
Ottawa 10
Rio de Janeiro 10
San Mateo 10
Toronto 10
Washington 10
Brno 8
Falkenstein 8
Mountain View 8
Nuremberg 8
São Paulo 8
Frankfurt am Main 7
Norwalk 7
Parma 7
Rome 7
Zhengzhou 7
Absecon 6
Addison 6
Belo Horizonte 6
Brasília 6
Curitiba 6
Hangzhou 6
Dublin 5
Guangzhou 5
Hefei 5
Jiaxing 5
Ningbo 5
The Dalles 5
Dhaka 4
Ferrara di Monte Baldo 4
Leawood 4
Leiden 4
Menlo Park 4
Modena 4
Porto Alegre 4
Shenzhen 4
Taizhou 4
Augusta 3
Bishkek 3
Chicago 3
Clifton 3
Evanston 3
Genova 3
Guarulhos 3
Indiana 3
Johannesburg 3
Minsk 3
Monmouth Junction 3
Napoli 3
Phoenix 3
Redmond 3
San Giovanni in Persiceto 3
Tappahannock 3
Verona 3
Vienna 3
Totale 5.593
Salva come PNG Salva come JPEG
Nome #
Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy 349
Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression 326
Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System 323
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 215
Crispr/Cas9-based COL7A1 editing for recessive dystrophic epidermolysis bullosa 201
Exploring Splicing-Switching Molecules For Seckel Syndrome Therapy 200
Transcriptomics analysis in collagen VI myopathy: Role of circadian genes using novel fluidic card tools 191
Omics approach and novel biostatistic tools identified RPL3L as potential genetic modifier of clinical severity in female carriers of Duchenne muscle dystrophy 177
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 177
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 170
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 169
Macrophages: a minimally invasive tool for monitoring collagen VI myopathies 169
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 167
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 164
Exon skipping-mediated dystrophin reading frame restoration for small mutations 162
Antisense-Induced Messenger Depletion Corrects a COL6A2 Dominant Mutation in Ullrich Myopathy 159
null 155
Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies 147
A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies 145
Correction of duplications in the DMD gene by a CRISPR/Cas9 approach 145
The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5 ' X-linked dilated cardiomyopathy 142
The DMD Locus Harbours Multiple Long Non-Coding RNAs Which Orchestrate and Control Transcription of Muscle Dystrophin mRNA Isoforms 142
Autosomal recessive Bethlem myopathy 136
G.P.12.06 A comprehensive molecular characterisation of dystrophinopathies 136
null 131
Transcriptional behavior of DMD gene duplications in DMD/BMD males 131
Rapid, comprehensive analysis of the dystrophin transcript by a custom micro-fluidic exome array 131
Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for X-linked dilated cardiomyopathy 130
D.P.12 Whole exome sequencing and RNAseq in a Duchenne-like female with no dystrophin mutations: Search for dystrophin gene modifiers 129
D.P.9 Whole exome sequencing filtered by novel candidate genes as tool for gene discovery in a recessive family with Parkinson and ataxia 124
Identification and characterization of novel collagen VI non-canonical splicing mutations causing ullrich congenital muscular dystrophy 123
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts 123
Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis 120
D.P.7 Whole exome sequencing as genetic diagnostic tool in myofibrillar myopathies 118
G.P.15 Whole transcriptome expression profiling in COL6a1 null mice shows deregulation of circadian clock genes as exploratory COL6 myopathies biomarkers 117
Prenatal diagnosis of Duchenne muscular dystrophy by comparative genomic hybridization 114
Correction of duplications in the DMD gene by a CRISPR/Cas9 approach 114
null 113
P1.19 Whole genetic and protein characterisation in DMD symptomatic female carriers excludes correlation with X-inactivation and transcriptional DMD allele balancing 111
T.P.2.07 The systemic administration of a low dose of 2OMePS-AON combined with novel cationic polymethylmethacrylate nanoparticles induces the rescue of dystrophin expression in the mdx murine model 107
EM.P.4.07 Autosomal recessive Bethlem myopathy 97
PLC-beta2 monitors the drug-induced release of differentiation blockade in tumoral myeloid precursors 92
Studio di CNVs nel locus HLA (6p21.32) mediante Array CGH in pazienti con Sclerosi Multipla e malformazioni venose 86
null 86
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients 86
CRISPR activation on coagulation F7 or F8 promoters potentiate trascriptional activity in the normal and mutated gene context 84
Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair 81
Antisense oligonucleotides conjugated with lipophilic compounds: synthesis and in vitro evaluation of exon skipping in duchenne muscular dystrophy 78
Exploiting The CRISPR/CAS9 System to Study Alternative Splicing In Vivo: Application to titin 74
Transcriptional enhancement as therapeutic approach of coagulation factor VII promoter mutations 71
MOLECULAR MECHANISMS AND THERAPEUTIC APROACHES FOR RESTORATION OF mRNA TRANSCRIPTION, MATURATION AND TRANSLATION IN INHERITED COAGULATION FACTOR DEFICIENCIES 66
Engineered transcription factors (TALE-TF) as potential therapeutic strategy for coagulation factor deficiencies caused by promoter mutations 61
Conjugates of oligonucleotides and bile acids and their derivatives for pharmaceutical active molecules delivery 56
In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment 52
Nanoparticle-Mediated Delivery of Antisense Oligoribonucleotides Allows Restoration of Dystrophin Expression in the mdx Mouse 51
Chromatin configuration, RNA and protein studies identified novel DNA elements that influence the dystrophin transcription dynamics 51
ncRNAs originating from the dystrophin gene as biomarker for assessing antisense therapy 48
Synthesis and exon‐skipping properties of a 3′‐ursodeoxycholic acid‐conjugated oligonucleotide targeting dmd pre‐mrna: Pre‐synthetic versus post‐ synthetic approach 48
Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice 45
A new rat model for Duchenne muscular dystrophy generated by CRISPR-induced deletion of Exon 45 42
Nanoparticles are effective vehicles for systemic delivery of 2 ' OMePS antisense oligonucleotides in exon skipping-mediated dystrophin restoration 40
Pre-trial antisense screening of myogenic cells from boys with Duchenne muscular dystrophy and genomic and transcriptomic biomarkers discovery for treatment monitoring 37
Efficient generation of mouse models with the CRISPR/Cas9 technology 37
G.P.3.02 In vivo biodistribution of non-viral systems for oligoribonucleotides delivery 35
Correction of exon 2, exon 2–9 and exons 8–9 duplications in DMD patient myogenic cells by a single CRISPR/Cas9 system 24
Targeted Genome Editing in Spinal Muscular Atrophy 24
Totale 7.955
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.582
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.582
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020210 0 0 0 0 0 0 0 0 0 120 45 45
2020/20211.053 99 69 75 125 53 75 90 99 52 139 121 56
2021/2022746 41 55 47 37 33 35 67 38 31 62 86 214
2022/2023812 75 82 8 111 154 93 52 63 85 11 44 34
2023/2024435 35 47 37 10 35 97 10 30 10 5 12 107
2024/20251.483 41 30 158 119 254 149 88 98 400 146 0 0
Totale 7.955